is weight watchers using semaglutide Inside WeightWatchers' fight to survive the Ozempic era Weight Watchers is now offering
Description
Orforglipron has demonstrated statistically significant improvements in blood sugar control in the ATTAIN trials for type 2 diabetes
Click on a star to rate it
The medication does not produce immediate weight loss
GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges
(2025) confirmed these patterns across the drug class: GLP-1 RAs significantly reduce lean mass (mean difference: 0.86 kg ), with the most potent agents for weight losssemaglutide 2.4 mg and tirzepatide 15 mgalso causing the greatest lean mass losses
The trial moved semaglutide from a weight loss tool into a recognised cardiovascular risk reduction therapy
